Pharvaris N.V. (PHVS)
PHVS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$30.02
-2.82% on the day
Market cap
$2.1B
Mid cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | PHVS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Netherlands |
| IPO year | 2021 |
| SEC CIK | 0001830487 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | P7 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-05-08 |
| Latest annual report | 20-F | 2026-04-02 |
| Latest quarterly / interim | 6-K | 2026-09-08 |
Source: SEC EDGAR submissions feed, 327 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -4.8% |
| 1 month | -20.8% |
| 3 months | -10.4% |
| Year to date | +8.7% |
| 1 year | +36.7% |
| From 52-week high | -22.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IMNM | Immunome Inc. | $17.58 | -8.20% | $2.1B |
| VRDN | Viridian Therapeutics Inc. | $18.22 | -0.44% | $2.1B |
| PRGO | Perrigo Company plc | $15.37 | -0.52% | $2.1B |
| HRMY | Harmony Biosciences Holdings Inc. | $37.03 | -3.14% | $2.2B |
| IRON | Disc Medicine Inc. | $56.60 | -6.42% | $2.2B |
| AUPH | Aurinia Pharmaceuticals Inc | $16.36 | -1.15% | $2.2B |
| BHC | Bausch Health Companies Inc. | $5.89 | -0.68% | $2.2B |
| SDGR | Schrodinger Inc. | $25.89 | -0.08% | $1.9B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier